Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
10-12 June, 2025
Not Confirmed
Not Confirmed
11-12 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
10-12 June, 2025
Industry Trade Show
Not Confirmed
11-12 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
18 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-secures-key-us-patent-allowance-for-cirara-in-treating-large-hemispheric-infarction-including-wake-up-strokes-302401375.html
18 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/international-stroke-conference-2025-remedy-pharmaceuticals-unveils-landmark-cirara-data-demonstrating-significant-improvements-in-stroke-outcomes-302378913.html
29 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-to-showcase-groundbreaking-phase-3-charm-study-data-on-cirara-at-international-stroke-conference-2025-302360948.html
19 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-receives-fda-guidance-to-advance-cirara-for-treatment-of-severe-stroke-302308921.html
22 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-announces-fda-orphan-drug-designation-granted-for-the-treatment-of-large-territory-acute-ischemic-stroke-with-cirara-302281446.html
01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-phase-3-trial-in-large-lesion-stroke-patients-demonstrates-statistically-significant-effect-at-one-year-302260511.html
ABOUT THIS PAGE